<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="130851">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01398540</url>
  </required_header>
  <id_info>
    <org_study_id>IX-sensesc 1.2</org_study_id>
    <nct_id>NCT01398540</nct_id>
  </id_info>
  <brief_title>Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine</brief_title>
  <official_title>Characterisation of Cellular and Humoral Immunity in Elderly People After Immunization With a Purified, Inactivated Japanese Encephalitis Vaccine.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      The aim of this project is to investigate humoral and cellular immune responses before and
      after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 65 years
      of age.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cellular immunity (cytokine production upon stimulation with Japanese Encephalitis Virus Antigen) 7 days after the 2. JE-vaccination</measure>
    <time_frame>7 days after the 2 JE vaccinations</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cellular Immunity in the Elderly (Above 65y) After Primary Vaccination Against JE</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>IXIARO</intervention_name>
    <description>2 immunizations (0,5ml) with a 28 day interval</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults (≥65 years),

          -  both sexes,

          -  willingness to sign written informed consent form

        Exclusion Criteria:

          -  age below 65 years

          -  status post japanese encephalitis, TBE, dengue, yellow fever or West Nile virus
             infection

          -  previous immunization against yellow fever, japanese encephalitis (dengue or WNV)

          -  current acute infection (body temperature above 37,9°C)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Wiedermann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Specific Prophylaxis and Tropical medicine, Vienna</affiliation>
  </overall_official>
  <verification_date>June 2010</verification_date>
  <lastchanged_date>July 19, 2011</lastchanged_date>
  <firstreceived_date>July 19, 2011</firstreceived_date>
  <responsible_party>
    <name_title>Prof. Dr. Ursula Wiedermann-Schmidt</name_title>
    <organization>: Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Encephalitis, Japanese</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
